MMED
MiniMed Group, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Jun 3 MiniMed reported Q4 FY2026 net sales of $837M (+15.6% YoY as reporte…
- Aug 31 ▼ Short interest jumps 36.7% to 8.06M
- Sep 1 ▲ MiniMed reported Q1 FY27 net sales of $843M (+16.6% YoY as reported,…
- Sep 14 ▲ MiniMed filed an S-4 registration statement for Medtronic's exchange…
- Sep 14 Medtronic plc is offering to exchange up to 225,361,295 newly issued…
- Sep 15 ▼ Short interest jumps 68.7% to 13.59M
- Sep 30 ▲ 4 funds open new positions (13F)
- Sep 30 ▼ Short interest jumps 33.9% to 18.20M
- Oct 7 Barclays initiates
- Oct 12 Jefferies initiates
- Oct 16 MiniMed completed its separation from Medtronic via an exchange offe…
- Oct 30 ▲ Short interest falls 52.8% to 9.81M
- Nov 16 New report: subscribers see the details Unlock
- Nov 16 New catalyst: subscribers see the details Unlock
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells since Mar 11. Recent filings are awards, exercises and tax withholding.
- InstitutionsBULLISH
Q3 2026: 29 added (4 new), 6 trimmed or exited. Largest new: Walleye Capital $27.2M, Hrt Financial $11.2M.
- AnalystsBULLISH
17 of 21 rate it Buy or better. Median target $27.00 (+45%).
- Short sellersCOVERING
Short interest −52.8% to 9.81M shares. 1.0 days to cover, ≈3.5% of shares.
- TrendDOWNTREND
4% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | DOUBLED | $66.3M |
| UBS Group AG | DOUBLED | $53.3M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | DOUBLED | $33.5M |
| Walleye Capital LLC | NEW | $27.2M |
| FIRST TRUST ADVISORS LP | DOUBLED | $16.0M |
| MORGAN STANLEY | DOUBLED | $15.3M |
| STATE STREET CORP | ADD | $13.6M |
| HRT FINANCIAL LP | NEW | $11.2M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
21 analystsPrice is inside the target range. Median implies +45%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 13, 2026 | Barclays MAINTAIN | Equal-Weight |
| Oct 12, 2026 | Jefferies INITIATE | Hold |
| Oct 8, 2026 | Mizuho MAINTAIN | Outperform |
| Oct 7, 2026 | Barclays INITIATE | Equal-Weight |
| Sep 24, 2026 | Truist Securities INITIATE | Buy |
| Sep 3, 2026 | Morgan Stanley MAINTAIN | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Dianaty Ali EVP Ch. Prod. & Tech Officer Oct 28, 2026 | TAX W/H | $8.5K |
Bricker Amy Director Oct 15, 2026 | AWARD | 11,877 sh |
Endicott David J. Director Oct 15, 2026 | AWARD | 3,374 sh |
Hopkins Robert (Bob) Director Oct 15, 2026 | AWARD | 11,877 sh |
Medtronic plc 10%+ Owner Oct 15, 2026 | OTHER | 252,813,348 sh |
Chandrasena Gillian SVP, Chief HR Officer Oct 15, 2026 | AWARD | 1,800 sh |
Dianaty Ali EVP Ch. Prod. & Tech Officer Oct 15, 2026 | AWARD | 11,108 sh |
Lofton Kevin E Director Oct 15, 2026 | AWARD | 836 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
24 filings · 1 press release · 2 bullish · 0 bearish · 4 mixed · 18 neutral- MIXED 8-KNov 16, 2026
MiniMed Group announced FDA clearance of its MiniMed Fit patch pump, its first tubeless insulin pump, several months ahead of expectations. The clearance triggers a $162 million one-time charge in Q3 FY2027 under a Blackstone Life Sciences agreement, reducing FY2027 adjusted EBITDA margin guidance…
🔒 Fresh report (last 24h), subscribers only
- BULLISH PRESS RELEASENov 16, 2026
MiniMed received FDA clearance for MiniMed Fit, its first tubeless insulin pump, which offers up to seven days of wear and a 300-unit insulin capacity. The clearance came ahead of schedule, with a phased U.S. launch expected in spring 2027.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL SC 13GNov 6, 2026
FMR LLC (Fidelity) filed a Schedule 13G disclosing a 13.5% passive stake in MiniMed Group as of…
Fidelity's 13.5% passive stake is a significant vote of confidence from a top-tier asset manager, likely providing a stable institutional base. Monitor for any future 13D conversion or additional…
- NEUTRAL SC 13GOct 22, 2026
Capital Ventures International, together with Susquehanna affiliates, disclosed a passive 7.8%…
Monitor for any subsequent amendment converting this 13G to a 13D, which would signal activist intent. The 7.8% stake is below the typical threshold for immediate activism but large enough to be…
All MMED filing & press-release reports (25)
- 8-K reportNov 16, 2026
- PRESS-RELEASE reportNov 16, 2026
- SC 13G reportNov 6, 2026
- SC 13G reportOct 22, 2026
- SC 13G/A reportOct 16, 2026
- 8-K reportOct 16, 2026
- EFFECT reportOct 6, 2026
- 3 reportOct 1, 2026
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- S-4, 425 reportSep 14, 2026
- 8-K reportSep 1, 2026
- 3 reportJul 6, 2026
- 8-K reportJun 29, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportJun 3, 2026
- 8-K reportMay 18, 2026
- 8-K reportApr 27, 2026
- 424B4 reportMar 6, 2026
- EFFECT reportMar 6, 2026
- S-1/A reportFeb 27, 2026